Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • BioGenomics
    Member
    • Apr 2009
    • 25

    ddRAD/GBS lib conc on HiSeq 3000/4000 ?

    Hi all,

    Has anybody any advice on the "best" concentration (pM) to load a ddRAD or GBS libraries on a HiSeq 3000/4000 ? ddRAD have 300-600 bp, while GBS more around 250-350 bp lib sizes. I know the longer fragments of ddRAD might create a problem may be with the new chemistry/patterned flowcells.

    Also 10% Phix would be ok ?

    Cheers,

    Greg
  • ATϟGC
    Member
    • Jun 2013
    • 56

    #2
    Hi,

    The optimal loading concentration and phiX % spike in will likely depend largely on the nucleotide sequence diversity at the start of your reads (on the HiSeq 2000 the first 12 bp is the most critical I think). Depending on how your ddRAD libraries were prepared they may be quite diverse (i.e. balanced proportions of each nucleotide at each position) or suffer from low sequence diversity. From what I read (http://support.illumina.com/sequenci...questions.html) the HiSeq 4000 still has low-diversity issues so it would be helpful if you could provide information as to how diverse the start of your reads are. A matrix of the nucleotide diversity for the first 12 bp like the one in the last post of the link below might help others give you recommendations.

    Bridged amplification & clustering followed by sequencing by synthesis. (Genome Analyzer / HiSeq / MiSeq)


    After having some run failures last year due to supposed nucleotide diversity issues on a hiseq 2000, we nearly perfect runs by adding some staggered barcodes to break up the restriction site, included a 15% phiX spike in, and clustered at 600-700K/mm^2.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
      by SEQadmin2


      Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

      The systematic characterization of the human proteome has
      ...
      Yesterday, 11:48 AM
    • SEQadmin2
      Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
      by SEQadmin2



      Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
      ...
      07-09-2026, 11:10 AM
    • SEQadmin2
      Cancer Drug Resistance: The Lingering Barrier to Rising Survival
      by SEQadmin2



      Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

      There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
      07-08-2026, 05:17 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, Yesterday, 11:10 AM
    0 responses
    9 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-13-2026, 10:26 AM
    0 responses
    30 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-09-2026, 10:04 AM
    0 responses
    40 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-08-2026, 10:08 AM
    0 responses
    25 views
    0 reactions
    Last Post SEQadmin2  
    Working...